Report Description
Global Cardiac Biomarkers Market is expected to grow at a CAGR of 9.6% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Cardiac Biomarkers Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:
KEY PLAYERS
ABBOTT LABORATORIES
ACS BIOMARKER BV
BECKMAN COULTER (PART OF DANAHER)
BG MEDICINE INC.
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
CARDIOGENICS
CAVADIS
CRITICAL DIAGNOSTICS
CRUINN MEDICAL LTD.
HEALTH-CHEM DIAGNOSTICS
LIFE DIAGNOSTICS INC.
LIFESIGN
LSI MEDIENCE CORP.
MERIDIAN LIFE SCIENCE INC.
METANOMICS HEALTH GMBH
MIRNEXT
ORTHO-CLINICAL DIAGNOSTICS INC.
PTS DIAGNOSTICS
RADIOMETER MEDICAL APS
RANDOX LABORATORIES LTD.
RESPONSE BIOMEDICAL CORP.
ROCHE (FORMERLY HOFFMANN-LA ROCHE LTD.)
SANYO CHEMICAL INDUSTRIES LTD.
SIEMENS AG
SINGULEX INC.
SPECTRAL MEDICAL, INC.
THERMO FISHER SCIENTIFIC
TOSOH BIOSCIENCE INC.
TRINITY BIOTECH PLC
ZENOSENSE INC.
Scope of the Market
Type Market
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW
Payment Options